Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 11Infertility 4hCG 1Uterine Anomalies 1Salpingitis 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Ovarian Hyperstimulation Syndrome 1Leiomyoma 1Infertility, Female 1Gonadal Disorders 1Endometritis 1Endometriosis 1Endocrine System Diseases 1Anovulation 1

Interventions

Gemcitabine 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Ocoxin 2Metformin 2Clomiphene 2relacorilant 1pralsetinib 1pembrolizumab 1parathyroid hormone-related peptide (1-36) 1niraparib 1napabucasin 1Spironolactone 1Paclitaxel 1Octreotide 1Leuprolide 1Irinotecan 1Immune Checkpoint Inhibitors 1Filgrastim 1Eating 1Cisplatin 1Chorionic Gonadotropin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Endocrine System Diseases × Chorionic Gonadotropin × Clear all
NCT00947713 2011-07-15

Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome

Royan Institute

Phase 1/2 Completed
10 enrolled

Endocrine System Diseases, Gonadal Disorders, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡